Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

XXX - Fructo-oligosaccharides / Oligofructose (FOS) vs Placebo (Maltodextrin) & Gut Microbiota

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

A prospective randomized, double- blind, placebo-controlled trial to investigate the efficacy of fructo-oligosaccharides (FOS) on human gut microflora

Consumption of Prebiotics Increased Bacterial Diversity
Tandon et al. 2019a

Fructo-oligosaccharides / Oligofructose / Fructans (FOS) consumption increased the relative abundance of OTUs belonging to Bifidobacterium and Lactobacillus
Tandon et al. 2019a

Higher Fructo-oligosaccharides / Oligofructose / Fructans (FOS) dosage appears to promote, in contrast to Maltodextrin, the selective proliferation of OTUs belonging to [Lactobacillus](brain://W104JYs6bkaILOvK0TgV1A/LacticaseibacillusLactob…

AI Chat

7/1/2026

Chat with our artificial intelligence: